AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

DOPAMINE HYDROCHLORIDE

7 registrations across 5 African markets— 7 active

Markets with DOPAMINE HYDROCHLORIDE

🇬🇭Ghana
2 registrations
2 active
🇿🇦South Africa
2 registrations
2 active
🇳🇬Nigeria
1 registration
1 active
🇹🇿Tanzania
1 registration
1 active
🇿🇼Zimbabwe
1 registration
1 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
DOPAMINE HYDROCHLORIDE INJECTION (Each ml contains Dopamine Hydrochloride 40mg)🇬🇭Ghana—activeOct 2030
DOPAMINE HYDROCHLORIDE INJECTION (Each ml contains Dopamine Hydrochloride 40mg)🇬🇭Ghana—activeOct 2030
PHARMA-Q DOPAMINE
SOLUTION; INJECTION
🇿🇼ZimbabwePHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALSactiveDec 2027
Dopamine Hydrochloride Injection**
Concentrate for solution for infusion
🇳🇬NigeriaExcel Charis Pharmaceutical Chemical LimitedactiveAug 2026
DOPAMINE-FAULDING 40 mg/ml🇿🇦South AfricaPfizer Laboratories (Pty) LtdactiveJan 1900
DOPAMINE HCl 200 mg/5 ml FRESENIUS🇿🇦South AfricaFresenius Kabi Manufacturing SA (Pty) LtdactiveJan 1900
Sterile Dopamine Concentrate 200mg/5ml
Solution for injection/concentrate for solution for infusion
🇹🇿TanzaniaMartindale Pharmaceuticals Ltd.active—

DOPAMINE HYDROCHLORIDE in Africa — Regulatory Overview

DOPAMINE HYDROCHLORIDE is registered across 5 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, South Africa, Nigeria, Tanzania and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 7 registrations, 7 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.